New stent aims to tackle tough heart blockages
NCT ID NCT07491107
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry will follow 2000 people with complex coronary artery disease who receive the Inspiron EVO drug-eluting stent. The stent is designed to be easier to deliver and stronger than standard stents. Researchers will track how well the stent works and whether it reduces heart attacks, death, or the need for repeat procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Inspiron EVO Drug-Eluting Stent
What this could lead to
If successful, this could show that the Inspiron EVO stent is a safe and effective option for treating complex coronary blockages, improving outcomes for patients with challenging heart disease.
What could go wrong
This is an observational registry, not a randomized trial, so results may be less definitive. The study is not yet recruiting, and real-world outcomes may vary. Risks include typical stent complications like blood clots or re-narrowing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
Porto Alegre, Rio Grande do Sul, 90610000, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••